Pfizer's Revenue by Region
In fiscal year , Pfizer's revenue by geographical region are as follows:
Learn more about Pfizer’s Revenue by Products
Check out competitors to Pfizer in a side-by-side comparison.
Explore additional financial metrics for Pfizer.
| Developed Europe | 21982000000 |
|---|---|
| Developed Rest Of World | 15778000000 |
| Emerging Markets | 20097000000 |
| UNITED STATES | 42473000000 |
| Developed Europe | 11650000000 |
|---|---|
| Developed Rest Of World | 7761000000 |
| Emerging Markets | 11996000000 |
| UNITED STATES | 27088000000 |
The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2022, Pfizer's revenue by region is as follows:
- Developed Europe generated $21.98B in revenue, representing 21.91% of its total revenue.
- Developed Rest Of World generated $15.78B in revenue, representing 15.73% of its total revenue.
- Emerging Markets generated $20.10B in revenue, representing 20.03% of its total revenue.
- UNITED STATES generated $42.47B in revenue, representing 42.33% of its total revenue.
The biggest region for Pfizer is the UNITED STATES, which represents 42.33% of its total revenue.
The smallest region for Pfizer is the Developed Rest Of World, which represents 15.73% of its total revenue.
The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2023, Pfizer's revenue by region is as follows:
- Developed Europe generated $11.65B in revenue, representing 19.92% of its total revenue.
- Developed Rest Of World generated $7.76B in revenue, representing 13.27% of its total revenue.
- Emerging Markets generated $12.00B in revenue, representing 20.51% of its total revenue.
- UNITED STATES generated $27.09B in revenue, representing 46.31% of its total revenue.
The biggest region for Pfizer is the UNITED STATES, which represents 46.31% of its total revenue.
The smallest region for Pfizer is the Developed Rest Of World, which represents 13.27% of its total revenue.
Summary Table
| Geography (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Developed Europe | 21.91% | 19.92% | 0% |
| Developed Rest Of World | 15.73% | 13.27% | 0% |
| Emerging Markets | 20.03% | 20.51% | 0% |
| UNITED STATES | 42.33% | 46.31% | 0% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
Related company
Related
-
Agilent Technologies Revenue by Region
-
Eli Lilly and Company Revenue by Region
-
Stryker Corporation Revenue by Region
-
Johnson & Johnson Revenue by Region
-
AbbVie Revenue by Region
-
Merck & Co. Revenue by Region
-
Thermo Fisher Scientific Revenue by Region
-
Abbott Laboratories Revenue by Region
-
Danaher Corporation Revenue by Region
-
Amgen Revenue by Region
-
Boston Scientific Corporation Revenue by Region
-
Bristol-Myers Squibb Company Revenue by Region
-
Cigna Corporation Revenue by Region
-
McKesson Corporation Revenue by Region
-
Cardinal Health Revenue by Region
-
Moderna Revenue by Region
